Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Evogene Ltd. (EVGN) Q3 2023 Earnings Call Transcript
12:21pm, Wednesday, 15'th Nov 2023
Evogene Ltd. (NASDAQ:EVGN ) Q3 2023 Earnings Conference Call November 15, 2023 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer
Evogene (EVGN) Reports Q2 Loss, Lags Revenue Estimates
09:31am, Thursday, 17'th Aug 2023
Evogene (EVGN) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.21 per share a year ago.
Evogene's Subsidiary Casterra: $11.3M Sale Of Castor Plant Seeds May Be Tip Of Iceberg
03:01am, Thursday, 06'th Jul 2023
Evogene's wholly-owned subsidiary Casterra Ag has received initial purchase orders worth $11.3 million for its proprietary castor plant seeds, which will be used for biofuel production in Africa. The
Evogene Ltd (EVGN) Q1 2023 Earnings Call Transcript
02:43pm, Thursday, 18'th May 2023
Evogene Ltd (NASDAQ:EVGN ) Q1 2023 Earnings Conference Call May 18, 2023 9:00 AM ET Company Participants Rachel Tamara - Evident, Head of Investor Relations Ofer Haviv - CEO & President Nir Arbel - Ch
Evogene (EVGN) Reports Q1 Loss, Misses Revenue Estimates
09:58am, Thursday, 18'th May 2023
Evogene (EVGN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.20 per share a year ago.
Evogene Ltd. (EVGN) Q4 2022 Earnings Call Transcript
12:11am, Friday, 10'th Mar 2023
Evogene Ltd. (NASDAQ:EVGN ) Q4 2022 Earnings Conference Call March 9, 2023 9:00 AM ET Company Participants Ofer Haviv - Chief Executive Officer Eyal Ronen - Executive Vice President, Business Developm
Evogene (EVGN) Reports Q4 Loss, Tops Revenue Estimates
09:53am, Thursday, 09'th Mar 2023
Evogene (EVGN) delivered earnings and revenue surprises of 66.67% and 20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Evogene Subsidiary Casterra Ag: Castor Seeds Benefiting From Changes In EU Laws
11:06pm, Tuesday, 21'st Feb 2023
Evogene's subsidiary Casterra has developed proprietary genomically modified, high-yield & high oil-content Castor seed varieties. In September 2022 the EU banned palm oil and soybean as a biofuel or
All You Need to Know About Evogene (EVGN) Rating Upgrade to Strong Buy
01:33pm, Wednesday, 18'th Jan 2023
Evogene (EVGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Evogene Ltd. (EVGN) Q3 2022 Earnings Call Transcript
02:32pm, Thursday, 17'th Nov 2022
Start Time: 09:00 January 1, 0000 9:34 AM ET Evogene Ltd. (NASDAQ:EVGN ) Q3 2022 Earnings Conference Call November 17, 2022, 09:00 AM ET Company Participants Ofer Haviv - President and CEO Yaron Eldad
Evogene (EVGN) Reports Q3 Loss, Tops Revenue Estimates
09:47am, Thursday, 17'th Nov 2022
Evogene (EVGN) delivered earnings and revenue surprises of 20% and 79.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Evogene to Present at the H.C. Wainwright 24th Annual Global Investment Conference
07:15am, Wednesday, 07'th Sep 2022
REHOVOT, Israel , Sept. 7, 2022 /PRNewswire/ -- Evogene Ltd.
EverGen Infrastructure: A Micro-Cap Renewable Energy Play
11:58pm, Monday, 05'th Sep 2022
EverGen Infrastructure is a leading RNG producer in Canada, supplying sustainable green gas that originates from organic waste. The company has significant potential upside instilled in its pipeline p
5 Weed Stocks That Smoked Headlines This Week
09:56am, Friday, 02'nd Sep 2022
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will co
Evogene Ltd. (EVGN) Q2 2022 Earnings Call Transcript
11:58am, Wednesday, 31'st Aug 2022
Evogene Ltd. (NASDAQ:EVGN ) Q2 2022 Earnings Conference Call August 31, 2022 9:00 AM ET Company Participants Ofer Haviv - President & CEO Russ Putland - EVP Commercial & General Manager, Lavie-Bio, In
